The Cyprus Cancer Research Institute (CCRI) is a Non for Profit aspiring to become a world class interdisciplinary research institute that will operate within a network of leading clinical and academic partners, namely the University of Cyprus (UCY), the Karaiskakio Foundation (KF) and the Bank of Cyprus Oncology Centre (BOCOC), aiming to promote excellence in the field of cancer research and in the development and utilization of innovative diagnostic and therapeutic approaches against this devastating disease. The Institute will bring together leading scientists working across different areas of biology and medical sciences to develop an internationally competitive program of research aiming to improve the current understanding on cancer pathogenesis and to develop novel therapeutic approaches against different cancer types.
Through state-of-the-art facilities, a strong multidisciplinary research team and links with world-leading institutions, the CCRI will lie at the center of a nexus of leading cancer researchers, oncologists, cancer service providers, scientists and academics, to create a National Cancer Research Network of Excellence, in so doing bringing Cyprus to the forefront of cancer research and cancer patient care. The CCRI will support basic and translational research projects for cancer prevention, diagnosis, and treatment. Through a rigorous and competitive academic and research program, state-of-the-art technology and a forward looking infrastructure, the CCRI will also operate as an incubator for the development and training of young scientists that will establish Cyprus as the hub of a leading scientific community focused on cancer research
Mission and Scope
The mission of the CCRI is to promote high caliber cancer research in Cyprus and to breed the next generation of cancer research scientists. The CCRI is anticipated to become a leading cancer research institute, spanning a wide spectrum of cancer research from investigating the molecular and cellular basis of cancer, to translational research and the development of new diagnostic and therapeutic approaches and practices.
The CCRI will build bridges with and transfer knowledge from centers of excellence abroad, create synergies with established centers in Cyprus, provide research opportunities, offer training and mentorship to young scientists and support a culture of entrepreneurship in cancer research.
Board of Directors
|1||Constantinos Christofides||Chairman||University of Cyprus|
|2||Lazaros Savvides||Vice-Chairman||Bank of Cyprus Oncology Center|
|3||Takis Klerides||Treasurer||Karaiskakio Foundation|
|4||Gerasimos Filippatos||Member||University of Cyprus|
|5||Georgia Panayiotou||Member||University of Cyprus|
|6||Constantinos Pitris||Member||University of Cyprus|
|7||Popi Kanari||Member||Karaiskakio Foundation|
|8||Pavlos Costeas||Member||Karaiskakio Foundation|
|9||Demetris Papamichael||Member||Bank of Cyprus Oncology Center|
|10||Charis Pouangare||Member||Bank of Cyprus Oncology Center|
|11||Clemente Pinedo||Member||The “George and Katy David” Foundation|
|12||Marina Soteriadou Petridou||Secretary (no voting rights)||University of Cyprus|
Interim Executive Administrative Committee
|1||Anastasia Constantinidou||Chairwoman||University of Cyprus|
|2||Pavlos Costeas||Vice-chairman||Karaiskakio Foundation|
|3||Marina Soteriadou Petridou||Secretary||University of Cyprus|
|4||Panos Ergatoudes||Member||Bank of Cyprus Oncology Center|